Skip to main content
PMC home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1996 Sep;5(4):257–261. doi: 10.1155/S0962935196000361

Inhibition of NO-synthase and degranulation of rat omental mast cells in vitro

A M Northover 1,✉, B J Northover 1
PMCID: PMC2365813  PMID: 18475736

Abstract

Mast cell amines, platelet-activating factor (PAF), thromboxanes and leukotrienes have been shown to be released during nitric oxide-synthase inhibition in the rat intestine. Mast cells in rat isolated omentum (OMCs) or isolated from the rat peritoneal cavity (PMCs) have been used here to investigate the relationship(s) between these agents. N-nitro-L-arginine methyl ester (L-NAME, 100 μM) caused some degranulation of OMCs, but no enhancement of histamine release from PMCs. PAF (5 μM) and U46619 (1 μM) degranulated OMCs and enhanced histamine release from PMCs. Pre-treatment of the omentum with BN52021 (10 μM) inhibited degranulation of OMCs in response to L-NAME, PAF or U46619. Pretreatment with 1-benzylimidazole (5 or 50 μM) inhibited the effect of L-NAME but not that of PAF. Indomethacin (1 μM) or sodium nitroprusside (10 μM) also inhibited the effects of L-NAME, but nordihydroguaiaretic acid (30 μM) did not. In PMCs BN52021 inhibited PAF-induced, but not U46619-induced, release of histamine. These results suggest that inhibition of nitric oxidesynthase in the omentum by L-NAME allows thromboxanes to release PAF, which in turn degranulates and releases histamine from OMCs.

Full Text

The Full Text of this article is available as a PDF (540.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boros M., Takaichi S., Masuda J., Newlands G. F., Hatanaka K. Response of mucosal mast cells to intestinal ischemia-reperfusion injury in the rat. Shock. 1995 Feb;3(2):125–131. [PubMed] [Google Scholar]
  2. Braquet P., Touqui L., Shen T. Y., Vargaftig B. B. Perspectives in platelet-activating factor research. Pharmacol Rev. 1987 Jun;39(2):97–145. [PubMed] [Google Scholar]
  3. Ellis H. V., 3rd, Johnson A. R., Moran N. C. Selective release of histamine from rat mast cells by several drugs. J Pharmacol Exp Ther. 1970 Dec;175(3):627–631. [PubMed] [Google Scholar]
  4. Gruetter C. A., Barry B. K., McNamara D. B., Gruetter D. Y., Kadowitz P. J., Ignarro L. Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine. J Cyclic Nucleotide Res. 1979;5(3):211–224. [PubMed] [Google Scholar]
  5. Kanwar S., Wallace J. L., Befus D., Kubes P. Nitric oxide synthesis inhibition increases epithelial permeability via mast cells. Am J Physiol. 1994 Feb;266(2 Pt 1):G222–G229. doi: 10.1152/ajpgi.1994.266.2.G222. [DOI] [PubMed] [Google Scholar]
  6. Kubes P., Wallace J. L. Nitric oxide as a mediator of gastrointestinal mucosal injury?-Say it ain't so. Mediators Inflamm. 1995;4(6):397–405. doi: 10.1155/S0962935195000640. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kurose I., Wolf R., Grisham M. B., Granger D. N. Modulation of ischemia/reperfusion-induced microvascular dysfunction by nitric oxide. Circ Res. 1994 Mar;74(3):376–382. doi: 10.1161/01.res.74.3.376. [DOI] [PubMed] [Google Scholar]
  8. Lefer A. M., Darius H. A pharmacological approach to thromboxane receptor antagonism. Fed Proc. 1987 Jan;46(1):144–148. [PubMed] [Google Scholar]
  9. Miller M. J., Grisham M. B. Nitric oxide as a mediator of inflammation?-You had better believe it. Mediators Inflamm. 1995;4(6):387–396. doi: 10.1155/S0962935195000639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Northover A. M., Northover B. J. Rat intestinal mast cell amines are released during nitric oxide synthase inhibition in vitro. Mediators Inflamm. 1996;5(1):32–36. doi: 10.1155/S0962935196000051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Rees D. D., Palmer R. M., Schulz R., Hodson H. F., Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol. 1990 Nov;101(3):746–752. doi: 10.1111/j.1476-5381.1990.tb14151.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Tai H. H., Yuan B. On the inhibitory potency of imidazole and its derivatives on thromboxane synthetase. Biochem Biophys Res Commun. 1978 Jan 13;80(1):236–242. doi: 10.1016/0006-291x(78)91128-2. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES